There are 398 resources available
183P - Efficacy and Safety of Tenalisib, a PI3K _/_ and SIK3 inhibitor in Patients with Locally Advanced or Metastatic Breast Cancer: Initial results from a Phase II study
Presenter: Tamta Makharadze
Session: Poster Display session
184P - Efficacy of adding an immune checkpoint inhibitor to chemotherapy in the first-line treatment of metastatic triple-negative breast cancer: A meta-analysis of randomized controlled trials
Presenter: yakup ergün
Session: Poster Display session
185P - Long Term Efficacy of Trastuzumab Biosimilar CT-P6 in Patients with HER2 Positive Early Breast Cancer: 6-year Survival Analysis of Phase III Study Results
Presenter: Sijin Park
Session: Poster Display session
186P - A Real-World Study on Prevalence of and Outcomes Related to Brain Metastases among Patients with HER2-Positive Metastatic Breast Cancer (mBC)
Presenter: Jenna Collins
Session: Poster Display session
187P - Development of a patient-centered core outcome set for metastatic breast cancer
Presenter: Kelly de Ligt
Session: Poster Display session
188P - Pooled analysis of two phase II randomised studies (NorBreast-231 & TEMPO Breast) evaluating weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)
Presenter: Laetitia Collet
Session: Poster Display session
189P - Pharmacokinetics (PK) of Sacituzumab Govitecan (SG) in Patients (Pts) With Metastatic Triple-Negative Breast Cancer (mTNBC) and Other Solid Tumors
Presenter: Indrajeet Singh
Session: Poster Display session
190P - Palbociclib treatment in pre/perimenopausal women with advanced/metastatic breast cancer (ABC/mBC): real-world patient characteristics, treatment patterns, and outcomes data from POLARIS
Presenter: Meghan Karuturi
Session: Poster Display session
191P - Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analisys.
Presenter: Fabio Marazzi
Session: Poster Display session
192P - Treatment patterns and outcomes of metastatic breast cancer (mBC) patients with HER2 IHC2+/ISH- status in the US
Presenter: Joanna MacEwan
Session: Poster Display session